InVivo Therapeutics Holdings Corp.
One Kendall Square, Suite B14402
Cambridge, MA 02139
March 3, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: InVivo Therapeutics Holdings Corp.
Registration Statement on Form S-1
File No. 333-236572
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, InVivo Therapeutics Holdings Corp. hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-236572), so that it may become effective at 5:15 p.m. on March 5, 2020, or as soon thereafter as practicable.
[Remainder of Page Intentionally Left Blank]
|
|
Very truly yours, | |
|
|
| |
|
|
INVIVO THERAPEUTICS HOLDINGS CORP. | |
|
|
| |
|
|
By: |
/s/ Richard Toselli |
|
|
Name: Richard Toselli | |
|
|
Title: President and Chief Executive Officer | |
Signature Page to Acceleration Request